BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16574904)

  • 21. Essential role for class II phosphoinositide 3-kinase alpha-isoform in Ca2+-induced, Rho- and Rho kinase-dependent regulation of myosin phosphatase and contraction in isolated vascular smooth muscle cells.
    Yoshioka K; Sugimoto N; Takuwa N; Takuwa Y
    Mol Pharmacol; 2007 Mar; 71(3):912-20. PubMed ID: 17179444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation by Ca2+/calmodulin of an exogenous myosin light chain kinase in mouse arteries.
    Raina H; Zacharia J; Li M; Wier WG
    J Physiol; 2009 Jun; 587(Pt 11):2599-612. PubMed ID: 19403597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.
    Dimopoulos GJ; Semba S; Kitazawa K; Eto M; Kitazawa T
    Circ Res; 2007 Jan; 100(1):121-9. PubMed ID: 17158339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthovanadate-Induced Vasoconstriction of Rat Mesenteric Arteries Is Mediated by Rho Kinase-Dependent Inhibition of Myosin Light Chain Phosphatase.
    Ito K; Matsuzaki M; Sasahara T; Shin M; Yayama K
    Biol Pharm Bull; 2015; 38(11):1809-16. PubMed ID: 26521832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboxane A2-induced bi-directional regulation of cerebral arterial tone.
    Neppl RL; Lubomirov LT; Momotani K; Pfitzer G; Eto M; Somlyo AV
    J Biol Chem; 2009 Mar; 284(10):6348-60. PubMed ID: 19095646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G protein-coupled estrogen receptor 1 mediates relaxation of coronary arteries via cAMP/PKA-dependent activation of MLCP.
    Yu X; Li F; Klussmann E; Stallone JN; Han G
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(4):E398-407. PubMed ID: 25005496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
    Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells.
    Woodsome TP; Polzin A; Kitazawa K; Eto M; Kitazawa T
    J Cell Sci; 2006 May; 119(Pt 9):1769-80. PubMed ID: 16608882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Smooth Muscle Myosin Light Chain Phosphatase by Multisite Phosphorylation of the Myosin Targeting Subunit, MYPT1.
    MacDonald JA; Walsh MP
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(1):4-13. PubMed ID: 29577868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response.
    Johnson RP; El-Yazbi AF; Takeya K; Walsh EJ; Walsh MP; Cole WC
    J Physiol; 2009 Jun; 587(Pt 11):2537-53. PubMed ID: 19359365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
    Aburima A; Wraith KS; Raslan Z; Law R; Magwenzi S; Naseem KM
    Blood; 2013 Nov; 122(20):3533-45. PubMed ID: 24100445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance.
    Dou D; Ma H; Zheng X; Ying L; Guo Y; Yu X; Gao Y
    Cardiovasc Res; 2010 Apr; 86(1):151-9. PubMed ID: 19939965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries.
    El-Yazbi AF; Johnson RP; Walsh EJ; Takeya K; Walsh MP; Cole WC
    J Physiol; 2010 May; 588(Pt 10):1747-62. PubMed ID: 20351047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation-dependent autoinhibition of myosin light chain phosphatase accounts for Ca2+ sensitization force of smooth muscle contraction.
    Khromov A; Choudhury N; Stevenson AS; Somlyo AV; Eto M
    J Biol Chem; 2009 Aug; 284(32):21569-79. PubMed ID: 19531490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Okadaic acid induces phosphorylation and translocation of myosin phosphatase target subunit 1 influencing myosin phosphorylation, stress fiber assembly and cell migration in HepG2 cells.
    Lontay B; Kiss A; Gergely P; Hartshorne DJ; Erdodi F
    Cell Signal; 2005 Oct; 17(10):1265-75. PubMed ID: 16038801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smooth muscle myosin phosphatase-associated kinase induces Ca2+ sensitization via myosin phosphatase inhibition.
    Borman MA; MacDonald JA; Murányi A; Hartshorne DJ; Haystead TA
    J Biol Chem; 2002 Jun; 277(26):23441-6. PubMed ID: 11976330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
    Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
    Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential signalling by muscarinic receptors in smooth muscle: m2-mediated inactivation of myosin light chain kinase via Gi3, Cdc42/Rac1 and p21-activated kinase 1 pathway, and m3-mediated MLC20 (20 kDa regulatory light chain of myosin II) phosphorylation via Rho-associated kinase/myosin phosphatase targeting subunit 1 and protein kinase C/CPI-17 pathway.
    Murthy KS; Zhou H; Grider JR; Brautigan DL; Eto M; Makhlouf GM
    Biochem J; 2003 Aug; 374(Pt 1):145-55. PubMed ID: 12733988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasodilatory effect of a novel Rho-kinase inhibitor, DL0805-2, on the rat mesenteric artery and its potential mechanisms.
    Yuan TY; Yan Y; Wu YJ; Xu XN; Li L; Jiao XZ; Xie P; Fang LH; Du GH
    Cardiovasc Drugs Ther; 2014 Oct; 28(5):415-24. PubMed ID: 25086815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
    Qi F; Ogawa K; Tokinaga Y; Uematsu N; Minonishi T; Hatano Y
    Anesth Analg; 2009 Aug; 109(2):412-7. PubMed ID: 19608811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.